766 related articles for article (PubMed ID: 16938406)
1. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.
McNamara RK; Levant B; Taylor B; Ahlbrand R; Liu Y; Sullivan JR; Stanford K; Richtand NM
Neuroscience; 2006 Nov; 143(1):141-53. PubMed ID: 16938406
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and cellular dopamine D
Lanza K; Meadows SM; Chambers NE; Nuss E; Deak MM; Ferré S; Bishop C
Neuropharmacology; 2018 Aug; 138():304-314. PubMed ID: 29936243
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a Go/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine.
Loos M; Staal J; Schoffelmeer AN; Smit AB; Spijker S; Pattij T
Behav Brain Res; 2010 Dec; 214(2):216-24. PubMed ID: 20580749
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
[TBL] [Abstract][Full Text] [Related]
6. The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion.
Pritchard LM; Newman AH; McNamara RK; Logue AD; Taylor B; Welge JA; Xu M; Zhang J; Richtand NM
Pharmacol Biochem Behav; 2007 Apr; 86(4):718-26. PubMed ID: 17408730
[TBL] [Abstract][Full Text] [Related]
7. A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice.
Harrison SJ; Nobrega JN
Psychopharmacology (Berl); 2009 Nov; 207(1):47-56. PubMed ID: 19662386
[TBL] [Abstract][Full Text] [Related]
8. Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding.
Bailey A; Metaxas A; Al-Hasani R; Keyworth HL; Forster DM; Kitchen I
Eur J Neurosci; 2010 Feb; 31(4):742-53. PubMed ID: 20384817
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
[TBL] [Abstract][Full Text] [Related]
10. The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.
Wang J; Jia Y; Li G; Wang B; Zhou T; Zhu L; Chen T; Chen Y
Int J Neuropsychopharmacol; 2018 May; 21(5):448-460. PubMed ID: 29390063
[TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.
Harrison SJ; Nobrega JN
Psychopharmacology (Berl); 2009 May; 204(1):49-59. PubMed ID: 19096829
[TBL] [Abstract][Full Text] [Related]
12. Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.
McNamara RK; Logue A; Stanford K; Xu M; Zhang J; Richtand NM
Synapse; 2006 Oct; 60(5):399-405. PubMed ID: 16856172
[TBL] [Abstract][Full Text] [Related]
13. Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats.
Zhang M; Ballard ME; Kohlhaas KL; Browman KE; Jongen-Rêlo AL; Unger LV; Fox GB; Gross G; Decker MW; Drescher KU; Rueter LE
Neuropsychopharmacology; 2006 Jul; 31(7):1382-92. PubMed ID: 16395300
[TBL] [Abstract][Full Text] [Related]
14. Biased G Protein-Independent Signaling of Dopamine D
Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
[TBL] [Abstract][Full Text] [Related]
15. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property.
Cote SR; Kuzhikandathil EV
Neuropharmacology; 2014 Apr; 79():359-67. PubMed ID: 24316466
[TBL] [Abstract][Full Text] [Related]
18. Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes.
Colelli V; Fiorenza MT; Conversi D; Orsini C; Cabib S
Genes Brain Behav; 2010 Oct; 9(7):703-11. PubMed ID: 20546314
[TBL] [Abstract][Full Text] [Related]
19. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains.
Ng GY; O'Dowd BF; George SR
Eur J Pharmacol; 1994 Nov; 269(3):349-64. PubMed ID: 7895774
[TBL] [Abstract][Full Text] [Related]
20. [A comparative genetic analysis of the role of the brain dopaminergic systems in the regulation of behavioral elements in the "open field" test in DBA/2J and C57BL/6J mice].
Kuligina ESh; Lebedev AA; Luchnikova EM
Genetika; 1997 Nov; 33(11):1529-33. PubMed ID: 9480216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
